JBS (JBS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
20 Dec, 2025Executive summary
Achieved record net revenue of $77.2 billion in 2024, up 6% year-over-year, with net income of $1.8 billion and adjusted EBITDA of $7.2 billion at a 9.3% margin, more than doubling the previous year.
Strong performance in Seara, Pilgrim's Pride, and JBS USA Pork, with Seara reaching a record 19.8% margin in Q4 and Pilgrim's Q4 margin rising to 14.7%.
Geographic and protein diversification enabled resilience and stable results despite U.S. market headwinds and challenging cattle cycles.
Significant shareholder returns: $759 million in dividends paid in October, $369 million in January, and a proposed $773 million dividend pending approval.
Employs over 280,000 people worldwide, operating more than 250 production facilities and selling to over 180 countries.
Financial highlights
2024 net revenue was $77.2 billion, with Q4 net revenue at $20 billion; adjusted EBITDA for 2024 was $7.2 billion (9.3% margin), and net profit was $1.8 billion.
Free cash flow for 2024 was $2.3 billion, up over 400% year-over-year; operating cash flow was $5.5 billion.
Net debt ended at $13.6 billion, down $1.7 billion from the prior year; leverage ratio reduced to 1.89x EBITDA.
Earnings per share in 2024 was $0.80, reversing a loss in 2023.
Capex for 2024 totaled $1.48 billion, focused on expansion and modernization.
Outlook and guidance
Management expects continued benefit from favorable cattle cycles in Australia and Brazil, with ongoing operational improvements and investments in innovation and biotechnology.
Free cash flow break-even for 2025 estimated at $4.5 billion, with $2 billion in capital expenditures planned.
Dual listing in the U.S. expected as early as Q3 2025, pending regulatory and shareholder approvals.
Ongoing investments in capacity expansion, efficiency, and new product categories, including entry into the egg market and expansion in Saudi Arabia and Nigeria.
Export revenue reached $20 billion in 2024, with Asia accounting for 49% of total exports.
Latest events from JBS
- Global protein leader with $91.2B revenue, rising margins, and strong global diversification.JBS
Institutional presentation - Record sales and improved cash flow offset by margin pressure and a net loss in 2Q26.JBS
Q2 2026 - Sustainable growth, margin expansion, and global diversification drive strong returns.JBS
Investor Day 2026 presentation - Global protein leader with $88.3B revenue, margin growth, and expanding global footprint.JBS
Investor presentation - Global protein leader with $88.3B revenue, expanding through diversification and strategic investment.JBS
Investor presentation - Net sales up 11% to $21.6B–$22B, but EBITDA and net income declined; leverage at 2.77x.JBS
Q1 2026 - Record $86.2B revenue and $2.02B net income in 2025, with margin pressure in North America.JBS
Q4 2025 - Record 3Q24: $19.9B revenue, $2.2B EBITDA, $693M profit, leverage at 2.15x.JBS
Q3 2024 - Q2 2024 saw record margins, $329M net profit, and strong cash flow, led by poultry and pork.JBS
Q2 2024